More Federal Help Is Needed to Address COVID-19 Crisis Facing Kidney Patients
In times of crisis, Americans always find a way to answer the call. The COVID-19 emergency, although unique to history, is no different. We are taking necessary precautions, maintaining social distance and helping our neighbors. We are following the science, observing guidelines and working together to flatten the curve — with the hope of saving…
Kidney Community Applauds the Administration’s Recently Announced Regulatory Relief for Kidney Care Providers and Patients
Recommendations from Kidney Care Partners Adopted and Approved by Administration WASHINGTON, DC – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers – today praised the Centers for Medicare & Medicaid Services (CMS) for taking action to expand telehealth services…
Amid Escalating COVID-19 Pandemic, Nation’s Kidney Care Community Calls on Congress and the Administration to Help Protect Vulnerable Patients, Frontline Care Providers
Americans with Kidney Failure Among the Most At-Risk; Cannot Miss Dialysis Care WASHINGTON – As the nation works to contain COVID-19 virus, the kidney care community urges Congress and the Administration to act quickly to protect individuals with chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as the caregivers who ensure dialysis…
KCP Statement on CMS’ Agreement to Classify Peritoneal Dialysis Catheters and Vascular Access As Essential Surgeries for Kidney Patients
Kidney Care Partners – the nation’s leading kidney care coalition comprised of patient advocates, dialysis professionals, care providers, researchers, and manufacturers dedicated to working together to improve quality of care for individuals living with kidney diseases – applauds the Centers for Medicare & Medicaid Services (CMS) for issuing a statement today clarifying its elective surgery…
A kidney disease moonshot is long overdue
What we need is a new “moonshot” for kidney care — that mirrors previous initiatives to tackle cancer. We need the collective energy, focus, incentives, and resources of both government and stakeholders — to bring diagnosis, treatment, access, choice, and delivery of quality kidney care into the 21st century. This will by far be our…
On World Kidney Day, the Kidney Community Acknowledges the Historic Alignment Between Public and Private Stakeholders on Key Policies to Improve Access, Choice and Innovation in Kidney Care
WASHINGTON, DC—Kidney Care Partners (KCP) – the nation’s leading coalition of more than 30 organizations comprised of patient advocates, dialysis professionals, care providers, researchers and manufacturers – acknowledges the historic alignment to address the public health care challenge among millions of Americans living with kidney disease. The Administration, Congress and the broader kidney care community…
Capitol Hill Briefing: The Future of Kidney Care in America
**In light of the coronavirus (COVID-19) outbreak situation, this briefing has been canceled and will be rescheduled for a later date.** We apologize for the inconvenience and thank you for your understanding. Participants from Congress, HHS, NIH and the Kidney Community will Discuss Bold Actions to Expand Choice, Improve Access and Foster Innovation in Kidney…
Nation’s Kidney Community Applauds Introduction of Legislation to Expand Access to Treatments for Individuals with Kidney Transplants
Bipartisan, Bicameral Legislation Would Extend Medicare Coverage of Immunosuppressive Drugs for Individuals with Kidney Transplants WASHINGTON, DC – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – today praised the introduction of the Comprehensive Immunosuppressive Drug Coverage for Kidney…
Statement from Kidney Care Partners on the Center for Medicare & Medicaid Services’ Proposed Changes to Medicare Advantage
Washington, DC — In response to the Centers for Medicare & Medicaid Services’ (CMS) announcement on proposed changes to the Medicare Advantage (MA) program, Kidney Care Partners (KCP) reiterated its strong support for action to provide Medicare beneficiaries with kidney failure – or end-stage renal disease (ESRD) — with access to MA plans. However, KCP…
MedPAC Eyes Axing ESRD Drug Add-On Pay As Trump Touts Kidney Care
Some kidney care stakeholders say the Medicare Payment Advisory Commission seems to be at odds with the administration over the need for innovation in treatments for end stage renal disease patients after commissioners at their January meeting leaned toward eliminating the transitional drug add-on payment adjustment to the ESRD pay bundle. But the payment advisors…